Stansberry Asset Management, LLC Nektar Therapeutics Transaction History

Stansberry Asset Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$30.43 - $56.65 $1.18 Million - $2.2 Million	-38,755 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$46.46 - $68.49 $1.52 Million - $2.24 Million	-32,758 Reduced 45.81%	38,755 $2.36 Million
Q2 2018 Aug 14, 2018	BUY	$46.25 - $104.45 $3.31 Million - $7.47 Million	71,513 New	71,513 $3.49 Million

145

139M

32.6K

14.1K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $146M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Stansberry Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Stansberry Asset Management, LLC with notifications on news.